Wilsele, Belgium

Sandrien Janssens

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Formac Pharmaceuticals N.v.. Active years: 2012.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sandrien Janssens: Innovator in Pharmaceutical Preparations

Introduction

Sandrien Janssens is a notable inventor based in Wilsele, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the preparation of solid dispersions. Her innovative methods have the potential to enhance drug delivery systems.

Latest Patents

Sandrien holds a patent for a preparation method for solid dispersions. This method involves the use of a polyvinyl alcohol-polyethylene glycol graft copolymer (PVA-PEG graft co-polymer) combined with BCS Class II or Class IV drugs. The process includes dissolving the copolymer in a water/alcohol mixture, preparing the drug solution in a second alcohol and organic solvent, and then mixing both solutions to achieve a specific concentration. The final step involves spray drying the mixture to create a solid dispersion.

Career Highlights

Sandrien Janssens is currently employed at Formac Pharmaceuticals N.V., where she continues to develop her innovative methods. Her work focuses on improving the solubility and bioavailability of pharmaceutical compounds, which is crucial for effective drug formulation.

Collaborations

One of her notable collaborators is Guy Van Den Mooter, who works alongside her in advancing pharmaceutical technologies.

Conclusion

Sandrien Janssens is a pioneering inventor whose work in solid dispersions is shaping the future of drug formulation. Her contributions are vital for enhancing the efficacy of pharmaceutical products.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…